stockrow
Friday 6 November 2026
Export VKTX’s income statement to Excel — free account
Viking Therapeutics, Inc.
VKTX Healthcare Biotechnology
- EPS
- −91.6%
- Free cash flow
- −47.0%
Quarter to September 2026, against a year earlier
26.79
1.00
+3.88%
Follow VKTX
Alert me
Viking Therapeutics, Inc. (VKTX) Total debt
Viking Therapeutics, Inc.'s total debt at the end of fiscal 2022 was $1.6M, up 5,293.1% from $29.0K in fiscal 2021. At the end of the quarter to 30 September 2026 it was $250.7M. Over the past ten years it has ranged from $29.0K (fiscal 2021) to $3.5M (fiscal 2017); the current reading is higher than 57% of that period. Viking Therapeutics, Inc. ranks 48th of 569 Biotechnology companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2022 | $1.6M | 5,293.10% |
| FY2021 | $29.0K | (91.92%) |
| FY2020 | $359.0K | (45.77%) |
| FY2019 | $662.0K | (80.82%) |
| FY2017 | $3.5M | 5.55% |
| FY2016 | $3.3M | 51.97% |
| FY2015 | $2.2M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $250.7M | 18,647.64% |
| Sep 2023 | $1.3M | (5.45%) |
| Jun 2023 | $1.4M | (5.10%) |
| Mar 2023 | $1.5M | (4.73%) |
| 29 more quarters | Free account |
Against its own ten years
Low $29.0K
High $3.5M
Ten-year median
$1.6M
Current reading's percentile
57
Total debt against peers
| Company | Total debt |
|---|---|
| CELC Celcuity, Inc. compare | $753.2M |
| VKTX Viking Therapeutics, Inc. | $250.7M |
| DYN Dyne Therapeutics, Inc. compare | $213.5M |
| TARS Tarsus Pharmaceuticals, Inc. compare | $72.9M |
| IRON Disc Medicine, Inc. compare | $59.3M |
| ACAD ACADIA Pharmaceuticals Inc. compare | $48.1M |
| XENE Xenon Pharmaceuticals Inc. compare | $11.0M |
| PBLS Parabilis Medicines, Inc. compare | $6.8M |
| ELVN Enliven Therapeutics, Inc. compare | $445.0K |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt